Artificial intelligence (AI) can use data from low-dose CT scans of the lungs to improve risk prediction for death from lung cancer, cardiovascular disease and other causes, according to a study published in Radiology, a journal of the Radiological Society of North America (RSNA).
Bavarian Nordic scraps RSV vaccine after PhIII trial misses the bar on preventing severe symptoms
Bavarian Nordic is scrapping its RSV program after its vaccine candidate flunked a large Phase III trial that had enrolled more than 20,000 elderly patients.